Clinical Features of Patients with an Epidermal Growth Factor Receptor T790M Mutation Detected in Circulating Tumor DNA.

CONCLUSIONS: Non-small cell lung carcinoma patients in whom an EGFR T790M mutation was detected in plasma samples demonstrated a poorer response to osimertinib than those in whom the mutation was detected in tissue specimens. PMID: 31494653 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31494653?dopt=Abstract

Source: Oncology - September 5, 2019 Category: Cancer & Oncology Authors: Ikushima H, Sakatani T, Usui K Tags: Oncology Source Type: research